Our Stroke portfolio delivers life-saving interventional solutions for patients with ischemic stroke for the best chance of a full recovery.
Our Vascular portfolio is transforming thrombectomy care for people suffering from devastating vascular diseases, including venous thromboembolism and acute limb ischemia.
We are developing the Telos robotic platform* to expand access to lifesaving care through purposeful design and innovation.
*Currently in development. Not approved for use or available for sale.
Imperative Care is addressing gaps across the entire patient journey to elevate care for patients suffering from stroke and other devastating vascular diseases.
Back to News
May 14, 2026
Imperative Care Appoints Jay Martin as Chief Commercial Officer
March 25, 2026
Imperative Care Initiates CLEAR-IT Clinical Study to Address Critical Gaps in Clinical Standards for Peripheral Thromboembolism
March 17, 2026
Imperative Care Announces $100 Million Financing
August 14, 2025
Chuck Alpuche Appointed to President and COO of Imperative Care
May 28, 2025
Imperative Care Announces Appointment of Tyler Binney to Board of Directors
April 22, 2025
Imperative Care Announces Appointment of Todd Van Horn to Chief Financial Officer
Media Contact
Rigo Magana
Corporate Communications
rmagana@imperativecare.com
Investor Contact
Phil Nalbone
VP of Corporate Development and Investor Relations
pnalbone@imperativecare.com
Contact us
